+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Live Cell Imaging Market Analysis, By Product Type By Application, By Technology By End Use, Forecasts To 2026

  • ID: 5356012
  • Report
  • August 2019
  • Region: Global
  • 250 pages
  • Reports and Data

FEATURED COMPANIES

  • Carl Zeiss
  • GE Healthcare
  • Leica Microsystems
  • Meditec AG
  • Molecular Devices
  • Nikon Corporation
Rising prevalence of various chronic diseases resulting in need for facilities to provide enhanced and faster diagnostics is a key factor driving market revenue growth.

Market Size - USD 2.18 Billion in 2020, Market Growth - CAGR of 9.1%, Market Trends - Constant focus on research and development for technological progressions and product launches by major players.

The global live cell imaging market size is expected to reach USD 4.35 Billion in 2028, and register a CAGR of 9.1% during the forecast period. Increasing adoption of live cell imaging by various major pharmaceutical companies in research, development, and launch of new as well as personalized medicines is a major factor expected to drive growth of the global live cell imaging market to a significant extent.

Live cell imaging allows researchers to observe and analyze cell structures in real time. These observations related to dynamic changes offers in-depth insights into operations of a cell better than snapshots provided by fixed-cell imaging.

However, high cost of content screening systems, and dearth of skilled professionals are major factors that could hamper growth of the global live cell imaging market.

Some Key Findings From the Report:
  • Among the product type segments, the instruments segment accounted for the largest revenue share of 39.5% in 2020, followed by the consumables segment in terms of revenue share.
  • Among the application segments, the cell biology segment accounted for major revenue share in 2020, and is expected to continue to contribute largest revenue share over the forecast period, due to growing number of researches on molecular interaction networks by major players.
  • In 2020, the Asia Pacific market size was USD 603.5 Million, owing to rising prevalence of various types of cancer, cardiovascular diseases, and diabetes, coupled with increasing initiatives taken by governments in countries in the region for research and development of treatment for these chronic diseases.
  • Key players profiled in the report include Carl Zeiss, Meditec AG, Leica Microsystems, Nikon Corporation, Becton, Dickinson and Company, GE Healthcare, Olympus Corporation, Thermo Fisher Scientific, Sigma-Aldrich Corporation, PerkinElmer and Molecular Devices. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global live cell imaging market is segmented on the basis of product type, technology, application, end use, and region:

Product Type Outlook (Revenue, USD Billion; 2018 - 2028)
  • Instruments
  • Microscopes
  • Cell Analyzers
  • Image Capturing
  • Consumables
  • Software
  • Others
Technology Outlook (Revenue, USD Billion; 2018 - 2028)
  • Fluorescence Resonance Energy Transfer (FRET)
  • Time Lapse Microscopy
  • Fluorescence Recovery After Photo-bleaching (FRAP)
  • High Content Screening (HCS)
  • Others
Application Outlook (Revenue, USD Billion; 2018 - 2028)
  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery
  • Others
End Use Outlook (Revenue, USD Billion; 2018 - 2028)
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Hospitals
  • Diagnostic Laboratories
  • Others
Region Outlook (Revenue, USD Billion; 2018 - 2028)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
Reasons to Buy the Report
  • A robust analysis and estimation of the Live Cell Imaging Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Live Cell Imaging Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Carl Zeiss
  • GE Healthcare
  • Leica Microsystems
  • Meditec AG
  • Molecular Devices
  • Nikon Corporation
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 - 2026

Chapter 3. Indicative Metrics
3.1. High adoption of high content screening systems
3.2. Global burden of chronic Applications
3.3. Worldwide cases of cardiovascular disorders

Chapter 4. Global Live Cell Imaging Segmentation & Impact Analysis
4.1. Global Live Cell Imaging Segmentation Analysis
4.2. Global Live Cell Imaging Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Global Live Cell Imaging Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. High prevalence of diabetes/cancer
4.4.1.2. Government funding for cell-based research
4.4.1.3. Rising prevalence of chronic Applications
4.4.2. Market restraint analysis
4.4.2.1. Lack of awareness
4.4.2.2. Lack of availability of skilled professionals
4.4.2.3. High cost of high content screening
4.5. Key opportunities prioritized
4.6. Global Live Cell Imaging Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Global Live Cell Imaging PESTEL Analysis

Chapter 5. Global Live Cell Imaging Market by Product Type Insights & Trends
5.1. Global Live Cell Imaging Type dynamics & Market Share, 2018 & 2026
5.2. Instruments
5.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.2.3. Microscopes
5.2.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.2.4. Cell analyzers
5.2.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.2.5. Image capturing
5.2.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.3. Consumables
5.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.4. Software
5.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.5. Others
5.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 6. Global Live Cell Imaging Market by Application Type Insights & Trends
6.1. Global Live Cell Imaging Application Type dynamics & Market Share, 2018 & 2026
6.2. Cell biology
6.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.3. Stem cells
6.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.4. Developmental Biology
6.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.5. Drug discovery
6.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.6. Other
6.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 7. Global Live Cell Imaging Market By Technology Type Insights & Trends
7.1. Global Live Cell Imaging Technology Type dynamics & Market Share, 2018 & 2026
7.2. Fluorescence resonance energy transfer (FRET)
7.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3. Time lapse Microscopy
7.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.4. Fluorescence recovery after photobleaching (FRAP)
7.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.5. High content screening (HCS)
7.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.6. Other
7.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 8. Global Live Cell Imaging Market By End Use Insights & Trends
8.1. Global Live Cell Imaging End Use dynamics & Market Share, 2018 & 2026
8.2. Pharmaceutical and Biotechnology Companies
8.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
8.3. Research Institutes
8.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
8.4. Hospitals
8.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
8.5. Diagnostic laboratories
8.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
8.6. Other
8.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 9. Global Live Cell Imaging Market Regional Outlook
9.1. Global Live Cell Imaging Market share by region, 2018 & 2026
9.2. North America
9.2.1. North America Global Live Cell Imaging Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.2. North America Global Live Cell Imaging Market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.2.3. North America Global Live Cell Imaging Market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.2.4. North America Global Live Cell Imaging Market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.2.5. North America Global Live Cell Imaging Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.2.6. U.S.
9.2.6.1. U.S. Global Live Cell Imaging Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.6.2. U.S. Global Live Cell Imaging Market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.2.6.3. U.S. Global Live Cell Imaging Market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.2.6.4. U.S. Global Live Cell Imaging Market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.2.6.5. U.S. Global Live Cell Imaging Market estimates and forecast by End use, 2016 - 2026, (USD Million)
9.2.7. Canada
9.2.7.1. Canada Global Live Cell Imaging Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.7.2. Canada Global Live Cell Imaging Market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.2.7.3. Canada Global Live Cell Imaging Market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.2.7.4. Canada Global Live Cell Imaging Market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.2.7.5. Canada Global Live Cell Imaging Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.3. Europe
9.3.1. Europe Global Live Cell Imaging Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.2. Europe Global Live Cell Imaging Market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.3.3. Europe Global Live Cell Imaging Market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.3.4. Europe Global Live Cell Imaging Market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.3.5. Europe Global Live Cell Imaging Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.3.6. Germany
9.3.6.1. Germany Global Live Cell Imaging Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.6.2. Germany Global Live Cell Imaging Market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.3.6.3. Germany Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.3.6.4. Germany Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.3.6.5. Germany Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.3.7. France
9.3.7.1. France Global Live Cell Imaging Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.7.2. France Global Live Cell Imaging Market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.3.7.3. France Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.3.7.4. France Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.3.7.5. France Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.3.8. U.K.
9.3.8.1. U.K Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.3.8.2. U.K Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.3.8.3. U.K. Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.3.8.4. U.K. Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.3.8.5. U.K. Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.3.9. Spain
9.3.9.1. Spain Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.3.9.2. Spain Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.3.9.3. Spain. Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.3.9.4. Spain Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.3.9.5. Spain Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.3.10. Italy
9.3.10.1. Italy Global Live Cell Imaging Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.10.2. Italy Global Live Cell Imaging Market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.3.10.3. Italy Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.3.10.4. Italy Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.3.10.5. Italy Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.3.11. Rest of Europe
9.3.11.1. Rest of Europe Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.3.11.2. Rest of Europe Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.3.11.3. Rest of Europe Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.3.11.4. Rest of Europe Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.3.11.5. Rest of Europe Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.4.2. Asia Pacific Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.4.3. Asia Pacific Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.4.4. Asia Pacific Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.4.5. Asia Pacific Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.4.6. China
9.4.6.1. China Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.4.6.2. China Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.4.6.3. China Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.4.6.4. China Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.4.6.5. China Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.4.7. Japan
9.4.7.1. Japan Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.4.7.2. Japan Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.4.7.3. Japan Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.4.7.4. Japan Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.4.7.5. Japan Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.4.8. India
9.4.8.1. India Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.4.8.2. India Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.4.8.3. India Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.4.8.4. India Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.4.8.5. India Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.4.9. Rest of Asia Pacific
9.4.9.1. Rest of Asia Pacific Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.4.9.2. Rest of Asia Pacific Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.4.9.3. Rest of Asia Pacific Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.4.9.4. Rest of Asia Pacific Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.4.9.5. Rest of Asia Pacific Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.5. Middle East & Africa
9.5.1. Middle East and Africa Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.5.2. Middle East and Africa Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.5.3. Middle East and Africa Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.5.4. Middle East and Africa Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.5.5. Middle East and Africa Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.6. Latin America
9.6.1. Latin America Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.6.2. Latin America Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.6.3. Latin America Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.6.4. Latin America Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.6.5. Latin America Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)
9.6.6. Brazil
9.6.6.1. Brazil Global Live Cell Imaging market estimates and forecast, 2016 - 2026, (USD Million)
9.6.6.2. Brazil Global Live Cell Imaging market estimates and forecast by Type, 2016 - 2026, (USD Million)
9.6.6.3. Brazil Global Live Cell Imaging market estimates and forecast by Application Type, 2016 - 2026, (USD Million)
9.6.6.4. Brazil Global Live Cell Imaging market estimates and forecast by Technology Type, 2016 - 2026, (USD Million)
9.6.6.5. Brazil Global Live Cell Imaging market estimates and forecast by End Use, 2016 - 2026, (USD Million)

Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Strategy Benchmarking
10.5. Vendor Landscape
Ch apter 11. Company Profiles
11.1. Carl Zeiss
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Length Benchmarking
11.1.4. Strategic Initiatives
11.2. Meditec
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Length Benchmarking
11.2.4. Strategic Initiatives
11.3. Leica Microsystems
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Length Benchmarking
11.3.4. Strategic Initiatives
11.4. Nikon Corporation
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Length Benchmarking
11.4.4. Strategic Initiatives
11.5. Becton
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Length Benchmarking
11.5.4. Strategic Initiatives
11.6. Dickinson and Company
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Length Benchmarking
11.6.4. Strategic Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Length Benchmarking
11.7.4. Strategic Initiatives
11.8. Olympus Corporation
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Length Benchmarking
11.8.4. Strategic Initiatives
11.9. Thermo Fisher Scientific
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Length Benchmarking
11.9.4. Strategic Initiatives
11.10. Sigma-Aldrich Corporation
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Length Benchmarking
11.10.4. Strategic Initiatives
11.11. PerkinElmer
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Length Benchmarking
11.11.4. Strategic Initiatives
11.12. Molecular Devices
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Length Benchmarking
11.12.4. Strategic Initiatives
Note: Product cover images may vary from those shown
  • Carl Zeiss
  • Meditec AG
  • Leica Microsystems
  • Nikon Corporation
  • Becton Dickinson and Company
  • GE Healthcare
  • Olympus Corporation
  • Thermo Fisher Scientific
  • Sigma-Aldrich Corporation
  • PerkinElmer
  • Molecular Devices
Note: Product cover images may vary from those shown
Adroll
adroll